Synthesis of the chelator lipid nitrilotriacetic acid ditetradecylamine (NTA-DTDA) and its use with the IAsys biosensor to study receptor-ligand interactions on model membranes.

This work describes the synthesis and use of the chelator lipid, nitrilotriacetic acid ditetradecylamine (NTA-DTDA). This lipid is readily dispersed in aqueous media, both alone and when mixed with carrier lipids like dimyristoylphosphatidylcholine (DMPC). Fluorescence microscopic examination of membranes deposited from NTA-DTDA-containing liposomes shows that NTA-DTDA mixes uniformly with the carrier lipid, and does not phase separate. NTA-DTDA-membranes deposited onto the sensing surface of IAsys biosensor cuvettes show good stability, permitting use of the biosensor to study protein interactions. Hexahistidine-tagged proteins including recombinant forms of the extracellular regions of murine B7.1 (B7.1-6H) and of the human erythropoietin receptor (EPOR-6H) bind to NTA-DTDA-membranes; the stability of binding is dependent on both protein concentration, and density of NTA-DTDA. Kinetic measurements show that high stability of anchored proteins (t(1/2) approximately 10-20 h, apparent K(d) approximately 1 nM) can be achieved using membranes containing 25 mol% NTA-DTDA, but low levels of bound protein (<200 arc seconds). The system is used to study the interaction of human EPO with the EPOR anchored onto NTA-DTDA-membranes. In addition to the biological applications reported recently, the results show that NTA-DTDA can be a useful reagent in the study of receptor-ligand interactions.

[1]  P. Brown,et al.  Two-dimensional crystallization of histidine-tagged, HIV-1 reverse transcriptase promoted by a novel nickel-chelating lipid. , 1994, Journal of structural biology.

[2]  Z. Dienes,et al.  Reversible oriented surface immobilization of functional proteins on oxide surfaces. , 1997, Analytical chemistry.

[3]  S. Ikemizu,et al.  CD2 and the nature of protein interactions mediating cell‐cell recognition , 1998, Immunological reviews.

[4]  A. Plant,et al.  Phospholipid/alkanethiol bilayers for cell-surface receptor studies by surface plasmon resonance. , 1995, Analytical biochemistry.

[5]  T. Satoh,et al.  CD4 dimerization and oligomerization: implications for T-cell function and structure-based drug design. , 1998, Immunology today.

[6]  S. Masuda,et al.  Production and ligand-binding characteristics of the soluble form of murine erythropoietin receptor. , 1992, Biochemical and biophysical research communications.

[7]  D. Williams,et al.  Surface plasmon resonance analysis at a supported lipid monolayer. , 1998, Biochimica et biophysica acta.

[8]  Frances H. Arnold,et al.  Metal-Affinity Separations: A New Dimension in Protein Processing , 1991, Bio/Technology.

[9]  J. Winkelmann,et al.  Ligand binding properties of the human erythropoietin receptor extracellular domain expressed in Escherichia coli. , 1992, The Journal of biological chemistry.

[10]  P. Gershon,et al.  Stable chelating linkage for reversible immobilization of oligohistidine tagged proteins in the BIAcore surface plasmon resonance detector. , 1995, Journal of immunological methods.

[11]  I. Gustafson,et al.  Planar lipid bilayers on solid supports from liposomes--factors of importance for kinetics and stability. , 1997, Biochimica et biophysica acta.

[12]  T. Arakawa,et al.  Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: one high-affinity and one low-affinity interaction. , 1996, Biochemistry.

[13]  R. Tampé,et al.  Orientation and Two-Dimensional Organization of Proteins at Chelator Lipid Interfaces , 1998, Biological chemistry.

[14]  Frances H. Arnold,et al.  Engineering protein-lipid interactions : targeting of histidine-tagged proteins to metal-chelating lipid monolayers , 1995 .

[15]  R. Tampé,et al.  Synthesis and Characterization of Chelator-Lipids for Reversible Immobilization of Engineered Proteins at Self-Assembled Lipid Interfaces , 1994 .

[16]  J. Altin,et al.  A novel system for convenient detection of low‐affinity receptor–ligand interactions: Chelator‐lipid liposomes engrafted with recombinant CD4 bind to cells expressing MHC class II , 2001, Immunology and cell biology.

[17]  L. Tamm,et al.  Formation of supported planar bilayers by fusion of vesicles to supported phospholipid monolayers. , 1992, Biochimica et biophysica acta.

[18]  P. Linsley,et al.  Covalent Dimerization of CD28/CTLA-4 and Oligomerization of CD80/CD86 Regulate T Cell Costimulatory Interactions* , 1996, The Journal of Biological Chemistry.

[19]  J. Altin,et al.  Differential Binding of Histidine-rich Glycoprotein (HRG) to Human IgG Subclasses and IgG Molecules Containing κ and λ Light Chains* , 1999, The Journal of Biological Chemistry.

[20]  S. Shaw,et al.  T-cell activation: Interplay at the interface , 1999, Current Biology.

[21]  W. Chiu,et al.  Electron crystallographic analysis of two-dimensional streptavidin crystals coordinated to metal-chelated lipid monolayers. , 1998, Biophysical journal.

[22]  R. Tampé,et al.  Molecular recognition of histidine-tagged molecules by metal-chelating lipids monitored by fluorescence energy transfer and correlation spectroscopy , 1998 .

[23]  R. Tampé,et al.  Molecular organization of histidine-tagged biomolecules at self-assembled lipid interfaces using a novel class of chelator lipids. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Smolyar,et al.  Molecular recognition of antigen involves lattice formation between CD4, MHC class II and TCR molecules. , 1995, Immunology today.

[25]  J. Altin,et al.  Histidine-rich glycoprotein binds to human IgG and C1q and inhibits the formation of insoluble immune complexes. , 1997, Biochemistry.

[26]  A. D’Andrea,et al.  Human erythropoietin receptor: cloning, expression, and biologic characterization. , 1990, Blood.

[27]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[28]  Michael Loran Dustin,et al.  Making the T cell receptor go the distance: a topological view of T cell activation. , 1997, Immunity.

[29]  R. Tampé,et al.  Design of supported membranes tethered via metal-affinity ligand-receptor pairs. , 2000, Biophysical journal.

[30]  R. Tampé,et al.  Functional immobilization of a DNA-binding protein at a membrane interface via histidine tag and synthetic chelator lipids. , 1996, Biochemistry.

[31]  H. Gaub,et al.  Lipid and lipid-protein monolayers spread from a vesicle suspension : a microfluorescence film balance study , 1990 .

[32]  V. Stevens.  Biosynthesis of glycosylphosphatidylinositol membrane anchors. , 1995, The Biochemical journal.

[33]  S. Jones,et al.  The extracytoplasmic domain of the erythropoietin receptor forms a monomeric complex with erythropoietin. , 1993, Blood.

[34]  G. Mosser,et al.  Two-dimensional crystallization on lipid layer: A successful approach for membrane proteins. , 1999, Journal of structural biology.

[35]  I. Poola,et al.  Ligand binding kinetics of a soluble full-length murine erythropoietin receptor. , 1995, Biochemical and biophysical research communications.

[36]  J. Lidholm,et al.  BIACORE analysis of histidine-tagged proteins using a chelating NTA sensor chip. , 1997, Analytical biochemistry.

[37]  P. Schultz,et al.  Specific interaction and two‐dimensional crystal‐lisation of histidine tagged yeast RNA polymerase I on Nickel‐chelating lipids , 1998, Biophysical journal.

[38]  I. Wilson,et al.  Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. , 1999, Science.

[39]  J. Altin,et al.  Engrafting Costimulator Molecules onto Tumor Cell Surfaces with Chelator Lipids: A Potentially Convenient Approach in Cancer Vaccine Development1 , 2000, The Journal of Immunology.